Literature DB >> 34136705

Nationwide Survey of Japanese Cardiac Rehabilitation Training Facilities During the Coronavirus Disease 2019 Outbreak.

Keisuke Kida1, Miho Nishitani-Yokoyama2, Shogo Oishi3, Yuji Kono4, Kentaro Kamiya5, Takuya Kishi6, Koichi Node7, Shigeru Makita8, Yutaka Kimura9.   

Abstract

Background: Since the reporting of a cluster outbreak of coronavirus disease 2019 (COVID-19) in sports gyms, the Japanese Association of Cardiac Rehabilitation (CR) shared a common understanding of the importance of preventing patients and healthcare providers from contracting COVID-19. This questionnaire survey aimed to clarify the status of CR in Japan during the COVID-19 outbreak. Methods and 
Results: An online questionnaire survey was conducted in 37 Japanese CR training facilities after the national declaration of a state of emergency in 7 prefectures. Among these facilities, 70% suspended group ambulatory CR and 43% suspended cardiopulmonary exercise testing (CPX). In contrast, all facilities maintained individual inpatient CR. Of the 37 facilities, 95% required CR staff to wear a surgical mask during CR. In contrast, 50% of facilities did not require patients to wear a surgical mask during CR. Cardiac telerehabilitation was only conducted by a limited number of facilities (8%), because this method was still under development. In our survey, 30% of the facilities not providing cardiac telerehabilitation had specific plans for its future use. Conclusions: Our data demonstrate that ambulatory CR and CPX were suspended to avoid the spread of COVID-19. In the future, we need to consider CR resumption and develop new technologies for cardiovascular patients, including cardiac telerehabilitation.
Copyright © 2021, THE JAPANESE CIRCULATION SOCIETY.

Entities:  

Keywords:  3Cs; Ambulatory cardiac rehabilitation; Cardiac telerehabilitation

Year:  2021        PMID: 34136705      PMCID: PMC8180369          DOI: 10.1253/circrep.CR-21-0042

Source DB:  PubMed          Journal:  Circ Rep        ISSN: 2434-0790


On April 1, 2020, the Japan Cardio-Vascular Alliance was established, and the Japanese Association of Cardiac Rehabilitation (JACR) joined the alliance. The initial focus of coronavirus disease 2019 (COVID-19) was primarily on infectious diseases, especially pneumonia, but it gradually became evident that vascular endothelial injury and thrombosis were significantly related to cardiovascular diseases. A nationwide survey in Japan by the Japanese Circulation Society reported both low clinical case experiences with COVID-19 and restrictions to cardiovascular procedures during the first COVID-19 wave in Japan. COVID-19 has become the global threat, and the number of infected patients in Japan has increased rapidly, particularly in the main urban areas. Although the Japan Cardio-Vascular Alliance was not initially established for COVID-19, it turned out to be a good timing as we were faced with an emergency situation that no one had ever experienced before. The Japanese Society of Cardiology organized a COVID-19 Task Force Mission Team to disseminate prompt information and to suggest collaborations with other departments and hospitals on April 10, 2020., The COVID-19 pandemic induced healthcare providers to change their respiratory management strategy for patients with acute heart failure (HF), especially in alert areas. Since the widespread reported of a cluster outbreak of COVID-19 in sports gyms, the JACR shared a common understanding of the importance of preventing patients and healthcare providers from contracting COVID-19. On April 7, 2020, the Japanese government first declared a national state of emergency over the novel coronavirus outbreak in 7 prefectures (Saitama, Chiba, Tokyo, Kanagawa, Osaka, Hyogo, and Fukuoka), including main urban areas, and announced the high risk of the occurrence of clusters when the 3Cs (closed spaces with poor ventilation; crowded places with many people nearby; close-contact settings, such as close-range conversation) overlap. It is quite difficult to avoid the 3Cs in cardiac rehabilitation (CR). Therefore, it is crucial that sufficient measures are enforced to prevent infection among healthcare providers and patients undergoing CR, as well as to prevent the spread of nosocomial infection, and to continuously provide appropriate and safe CR and cardiopulmonary exercise testing (CPX). Studies have reported the status of CR in Japan before the COVID-19 outbreak.– Recently, one facility reported that the participation rate of HF patients in a remote CR program increased during the COVID-19 pandemic in Japan. However, to the best of our knowledge, we have no data from detailed studies concerning the CR situation in Japan during the COVID-19 outbreak; thus, investigating the current CR situation is an urgent issue. In this study, we used a questionnaire to determine what measures were taken in CR training facilities against the COVID-19 outbreak after the Japanese government’s declaration of a state of emergency.

Methods

An online questionnaire was created Google Form and emailed to 40 Japanese CR training facilities on April 13, 2020, after the declaration of a state of emergency in 7 major prefectures but before the nationwide declaration. The data obtained were compiled by the Public Relations Committee of the JACR. The questionnaire included basic information for each of the facilities, exercise therapy implementation, exercise testing, cardiac telerehabilitation, patient guidance, and other aspects affecting CR implementation and education. Based on the results of the questionnaire, we assessed differences among facilities (between those accepting patients with COVID-19 and those not) and regions (between those under a state of emergency and those not).

Ethical Considerations

The study protocol was approved by the St. Marianna University School of Medicine Institutional Committee on Human Resource, Kawasaki, Japan (No. 4863). The study was performed in accordance with the Declaration of Helsinki.

Statistical Analysis

Categorical data are expressed as numbers and percentages. Intergroup differences were evaluated using Fisher’s exact test for categorical variables. Statistical analyses were conducted using JMP® Pro 14.2.0.

Results

Of the 40 Japanese CR training facilities that received the questionnaire, 37 (92.5%) completed the survey: 13 facilities in the Kanto region, 7 each in the Kinki and Kyushu regions, 3 in the Tohoku region, 2 each in the Hokkaido and Chugoku regions, and 1 each in the Tokai, Hokuriku and Shikoku regions (). Of the 37 facilities (22 university hospitals, 15 general hospitals), 28 (76%) accepted patients with COVID-19 and 10 (37%) encountered COVID-19 cases.
Figure.

Distribution of cardiac rehabilitation (CR) facilities during the COVID-19 outbreak in Japan. The areas delineated by the red lines on the map show regions where the Japanese government first declared a national state of emergency because of the novel coronavirus outbreak (7 prefectures: Saitama, Chiba, Tokyo, Kanagawa, Osaka, Hyogo, and Fukuoka). The source of the figure is the Geographical Survey Institute (https://maps.gsi.go.jp/development/ichiran.html).

Distribution of cardiac rehabilitation (CR) facilities during the COVID-19 outbreak in Japan. The areas delineated by the red lines on the map show regions where the Japanese government first declared a national state of emergency because of the novel coronavirus outbreak (7 prefectures: Saitama, Chiba, Tokyo, Kanagawa, Osaka, Hyogo, and Fukuoka). The source of the figure is the Geographical Survey Institute (https://maps.gsi.go.jp/development/ichiran.html). Of the 37 facilities, 70% suspended group ambulatory CR (). There were no significant differences in the suspension of group ambulatory CR between facilities that did and did not accept patients with COVID-19 (32% vs. 22%, respectively; P=0.57) or between regions under a state of emergency and those not (21% vs. 39%, respectively; P=0.24). The suspension of inpatient group CR was decided by individual facilities; 51% of facilities continued group CR and the remaining 49% suspended group CR. There were no significant differences in the suspension of inpatient group CR between facilities that did and did not accept patients with COVID-19 (57% and 33%, respectively; P=0.21) or between regions under a state of emergency and those not (53% and 50%, respectively; P=0.87). In contrast, all facilities maintained individual inpatient CR.
Table 1.

Status of Cardiac Rehabilitation Facilities During the COVID-19 Outbreak

Survey itemsAll (n=37)Facility statusFacility regions
Accepting COVID-19 patients (n=28)Not accepting COVID-19 patients (n=9)P valueIn a state of emergencyA (n=19)Not in a state of emergency (n=18)P value
Continuing group ambulatory CR: Yes11 (30)9 (32)2 (22)0.574 (21)7 (39)0.24
Continuing group inpatient CR: Yes19 (51)16 (57)3 (33)0.2110 (53)9 (50)0.87
Continuing individual inpatient CR: Yes37 (100)28 (100)9 (100)19 (100)18 (100)
Cancellations of ambulatory CR from patients: Yes29 (78)22 (79)7 (78)0.9616 (84)13 (72)0.38
Requirement for CR staff to wear surgical masks during CR: Yes35 (95)27 (96)8 (89)0.3818 (95)17 (94)0.97
Requirement for patients to wear surgical masks during CR: Yes17 (46)12 (43)5 (56)0.518 (42)9 (50)0.63
Disinfection before and after CR: Yes33 (89)25 (89)8 (89)0.9716 (84)17 (94)0.32
Modified regular CR: Yes33 (89)25 (89)8 (89)0.9717 (89)16 (89)0.95
Continuing treadmill test: Yes24 (65)18 (64)6 (67)0.9010 (53)14 (78)0.11
Continuing CPX: Yes21 (57)15 (54)6 (67)0.498 (42)13 (72)0.06
Modified regular CPX: Yes21 (57)17 (61)4 (44)0.3911 (58)10 (56)0.89
Conducting remote CR programs: Yes3 (8)1 (4)2 (22)0.073 (16)0 (0)0.08
Continuing patient education for inpatients: Yes6 (16)6 (21)0 (0)0.134 (21)2 (11)0.41
Changes in instructional content: Yes17 (46)15 (54)2 (22)0.1010 (53)7 (39)0.40

Unless indicated otherwise, data are presented as n (%). ASaitama, Chiba, Tokyo, Kanagawa, Osaka, Hyogo, and Fukuoka. CPX, cardiopulmonary exercise testing; CR, cardiac rehabilitation.

Status of Cardiac Rehabilitation Facilities During the COVID-19 Outbreak Unless indicated otherwise, data are presented as n (%). ASaitama, Chiba, Tokyo, Kanagawa, Osaka, Hyogo, and Fukuoka. CPX, cardiopulmonary exercise testing; CR, cardiac rehabilitation. Of the 37 facilities, 95% required CR staff to wear a surgical mask during CR. In contrast, 50% of facilities did not require patients to wear a surgical mask during CR. No facilities status and regional differences were observed in 90% of the facilities disinfected the CR room before and after each CR session (89% and 89%, P=0.97; 84% and 94%, P=0.32, respectively). Of the 37 facilities, 65% continued with treadmill testing, whereas approximately half the facilities in areas under a state of emergency decided to suspend it. CPX was suspended in 43% of facilities, including 58% of facilities in areas under a state of emergency (vs. 28% in areas not under a state of emergency), and this decision greatly varied according to region. Cardiac telerehabilitation was only conducted by a limited number of facilities (8%), because this method was still under development. In our survey, 30% of the facilities not providing cardiac telerehabilitation had specific plans for its future use. From the survey results, 84% of facilities suspended group inpatient education. Because alternative items were not included in the questionnaire, it was assumed that group inpatient education shifted to individualized instruction. The details remain unclear. With the spread of COVID-19, approximately half the surveyed CR facilities have made additional changes to their instructions and procedures.

Discussion

Many departments restricted their cardiological procedures, and this rate changed according to the pandemic situation. The exacerbation of cardiovascular disease resulting from pandemic restrictions should not be ignored. This survey included 19 facilities (51%) located in the 7 prefectures where the state of emergency was first declared on April 7, 2020. The declaration of a state of emergency was expanded nationwide on April 16, 2020. This survey had been conducted before the CR guidance was published by the Japanese Association of Cardiac Rehabilitation on April 20, 2020, and each facility’s decision appeared to be based on whether the facilities was in an area under the state of emergency, and not whether the facility was accepting patients with COVID-19. Of note, 80% of the facilities experienced ambulatory CR cancellations from patients. This suggests an improved awareness of patients, which was one of the main objectives in ambulatory CR., Notably, 89% of the facilities took various measures to avoid the 3Cs in both group and individual CR at the discretion of each facility (). These detailed measures should be promptly shared by all CR facilities.
Table 2.

How to Avoid the 3Cs (Closed Spaces, Crowded Places, and Close-Contact Settings) in CR

Closed spaces with poor ventilation
 • Ensure regular ventilation of the rehabilitation room
 • Consider the well-organized placement of patients
Crowded places with many people nearby
 • Change group exercise therapy sessions to individualized instruction (1 : 1 sessions)
 • Reduce the number of patients in each session as much as possible
 • Provide CR to inpatients in hospital wards and not in rehabilitation rooms where other rehabilitation patients gather
Close-contact setting, such as close-range conversation
 • When using cycle ergometers and treadmills, keep a minimum distance of 2 m between patients
 • Ensure all patients and CR staff wear surgical masks
 • Avoid cough-inducing exercises

CR, cardiac rehabilitation.

How to Avoid the 3Cs (Closed Spaces, Crowded Places, and Close-Contact Settings) in CR CR, cardiac rehabilitation. When we perform CPX, we are at risk of infection exposure from the respiratory droplets of patients coughing, which can cause viral aerosolization. Approximately 60% of facilities decided to conduct inspections and established infection control measures. Decisions regarding stress exercise testing, including CPX, should be based on individualized risk assessment and a patient’s clinical status. Shared decision making between the patients and the CR team is an important component. Cardiac telerehabilitation was only conducted by a limited number of facilities at the time of the survey because this method was still under development. In our survey, 30% of facilities not providing cardiac telerehabilitation had specific future plans, suggesting the possibility of further development of cardiac telerehabilitation during the COVID-19 outbreak.– For safe CR during the COVID-19 pandemic: • to avoid crowds, group rehabilitation and instruction should be suspended • to avoid excessive (patient) resting, CR staff should allow patients to walk about in a restricted area under certain conditions and instruct them as to how to perform aerobic exercises and muscle strength training at home • to avoid further spread of COVID-19, the use of face masks and hand washing are compulsory. The status of CR was assessed based on the results of the questionnaire. The data obtained demonstrated that ambulatory CR and CPX were suspended to prevent the spread of COVID-19. Thus, it is essential to identify measures that should be taken at appropriate times. At present, there is a need to establish new CR strategies for continuous prevention in cardiovascular patients, such as the development of new technologies providing appropriate and safe CR even during a pandemic., We believe that we will be able to provide appropriate and safe CR to medical professionals and patients even during the COVID-19 outbreak by using suitable guidelines and cardiac telerehabilitation.

Conclusions

Our data demonstrated that ambulatory CR and CPX were suspended to avoid the spread of COVID-19. In the future, we need to consider CR resumption and develop new technologies for cardiovascular patients, including cardiac telerehabilitation.

Sources of Funding

This study did not receive any specific funding.

Disclosures

K.N. is a member of Circulation Reports’ Editorial Team. The remaining authors report no potential conflicts of interest.

IRB Information

The study protocol was approved by the St. Marianna University School of Medicine Institutional Committee on Human Resource, Kawasaki, Japan (No. 4863). Supplementary Appendix
  14 in total

1.  Coronavirus Disease 2019 (COVID-19) Information for Cardiologists - Systematic Literature Review and Additional Analysis.

Authors:  Tadafumi Sugimoto; Atsushi Mizuno; Takuya Kishi; Naoya Ito; Chisa Matsumoto; Memori Fukuda; Nobuyuki Kagiyama; Tatsuhiro Shibata; Takashi Ohmori; Shogo Oishi; Jun Fuse; Keisuke Kida; Fujimi Kawai; Mari Ishida; Shoji Sanada; Issei Komuro; Koichi Node
Journal:  Circ J       Date:  2020-04-29       Impact factor: 2.993

2.  Poor implementation of cardiac rehabilitation despite broad dissemination of coronary interventions for acute myocardial infarction in Japan: a nationwide survey.

Authors:  Yoichi Goto; Muneyasu Saito; Toshiji Iwasaka; Hiroyuki Daida; Masahiro Kohzuki; Kenji Ueshima; Shigeru Makita; Hitoshi Adachi; Hiroyoshi Yokoi; Kazuto Omiya; Hiroshi Mikouchi; Hiroyuki Yokoyama
Journal:  Circ J       Date:  2007-02       Impact factor: 2.993

3.  Nationwide Survey of Multidisciplinary Care and Cardiac Rehabilitation for Patients With Heart Failure in Japan - An Analysis of the AMED-CHF Study.

Authors:  Kentaro Kamiya; Takanobu Yamamoto; Miyuki Tsuchihashi-Makaya; Toshimi Ikegame; Tetsuya Takahashi; Yukihito Sato; Norihiko Kotooka; Yoshihiko Saito; Hiroyuki Tsutsui; Hiroaki Miyata; Mitsuaki Isobe
Journal:  Circ J       Date:  2019-06-11       Impact factor: 2.993

4.  Standard Cardiac Rehabilitation Program for Heart Failure.

Authors:  Hideo Izawa; Toshiko Yoshida; Toshimi Ikegame; Kazuhiro P Izawa; Yoshihiro Ito; Hideo Okamura; Naohiko Osada; Shintaro Kinugawa; Takuro Kubozono; Yuji Kono; Kiyonori Kobayashi; Kazuhiko Nishigaki; Taiki Higo; Akihiro Hirashiki; Yasushi Miyazawa; Yuji Morio; Masanobu Yanase; Sumio Yamada; Hisao Ikeda; Shin-Ichi Momomura; Yasuki Kihara; Kazuhiro Yamamoto; Yoichi Goto; Shigeru Makita
Journal:  Circ J       Date:  2019-11-09       Impact factor: 2.993

5.  COVID-19: A Time for Alternate Models in Cardiac Rehabilitation to Take Centre Stage.

Authors:  Abraham Samuel Babu; Ross Arena; Cemal Ozemek; Carl J Lavie
Journal:  Can J Cardiol       Date:  2020-04-25       Impact factor: 5.223

6.  Future-proofing cardiac rehabilitation: Transitioning services to telehealth during COVID-19.

Authors:  Emma Thomas; Robyn Gallagher; Sherry L Grace
Journal:  Eur J Prev Cardiol       Date:  2020-05-05       Impact factor: 7.804

7.  Cardiology Department Practices in the First Wave of the Coronavirus Disease Pandemic - A Nationwide Survey in Japan by the Japanese Circulation Society.

Authors:  Atsushi Mizuno; Chisa Matsumoto; Daisuke Yoneoka; Takuya Kishi; Mari Ishida; Shoji Sanada; Memori Fukuda; Yoshihiko Saito; Keiko Yamauchi-Takihara; Hiroyuki Tsutsui; Keiichi Fukuda; Issei Komuro; Koichi Node
Journal:  Circ Rep       Date:  2021-02-05

8.  Remote cardiac rehabilitation is a good alternative of outpatient cardiac rehabilitation in the COVID-19 era.

Authors:  Atsuko Nakayama; Naoko Takayama; Momoko Kobayashi; Kanako Hyodo; Naomi Maeshima; Fujiwara Takayuki; Hiroyuki Morita; Issei Komuro
Journal:  Environ Health Prev Med       Date:  2020-09-05       Impact factor: 3.674

9.  Cardiology Department Policy in Japan After Coronavirus Disease-2019 (COVID-19) - Descriptive Summary of 2nd Nationwide Survey by the Japanese Circulation Society.

Authors:  Atsushi Mizuno; Chisa Matsumoto; Takuya Kishi; Mari Ishida; Shoji Sanada; Memori Fukuda; Issei Komuro; Kenichi Hirata; Koichi Node
Journal:  Circ Rep       Date:  2021-01-29

10.  Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic.

Authors:  Tee Joo Yeo; Yi-Ting Laureen Wang; Ting Ting Low
Journal:  Eur J Prev Cardiol       Date:  2020-04-01       Impact factor: 8.526

View more
  1 in total

Review 1.  Cardiovascular considerations during the COVID-19 pandemic: A focused review for practice in Japan.

Authors:  Daiki Tomidokoro; Yukio Hiroi
Journal:  Glob Health Med       Date:  2022-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.